Resultado da Busca
Há 3 horas · Yello was back at the workshop, working. As usual, the workshop was quite hot, and the AC did not work properly. She was sweating profusely, and thus opened her orange jumpsuit, letting her ample breasts almost spill out. She opened her suit almost to the point of revealing her nether regions. but at least the heat was a bit more bearable.Of course, her co-workers were massively distracted by ...
Há 12 horas · NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central ...
Há 12 horas · Nowy zarząd Komitetu Nauk Neurologicznych PAN. Nowym przewodniczącym został wybrany prof. Dariusz Jaskólski, który pełni funkcję kierownika Katedry i Kliniki Neurologii na Uniwersytecie Medycznym w Łodzi. Jest on również prezesem-elektem Polskiego Towarzystwa Neurochirurgów.
Há 12 horas · 05/23/2024 - 08:00 AM . NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today highlights data presentations at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting being held in Miami, May 28 - 31 ...
Há 12 horas · New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease. The study also found several lupus-specific symptoms that predict stroke and IHD in these patients. Details of the study was presented at ACR Convergence, the American College Rheumatology ...
Há 35 minutos · Intra-Cellular Therapies, Inc. Juan Sanchez, M.D. Vice President, Corporate Communications and Investor Relations. 646-440-9333. Burns McClellan, Inc. Cameron Radinovic / Lee Roth. cradinovic ...
Há 34 minutos · Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.
